Montreal, October 14, 2025 – Aplantex Bio is proud to announce a new partnership with Symrise AG, a global leader in natural ingredients, to develop and produce hard-to-source plant-based molecules using Aplantex’s advanced green biotechnology platform.
This partnership highlights the strength of our technology and our commitment to sustainable production
“Aplantex’s innovative process shows strong potential to secure access to rare plant-based molecules, especially in the context of climate change,” said Dr. Jakob Ley, Director of Biobased Ingredients Research at Symrise.
Since 2024, Aplantex has been working on the first molecule of interest for Symrise. Building on its success producing apigenin, orientin, vitexin, and luteolin—molecules known for their antioxidant, anti-inflammatory, and anti-aging properties—the company has rapidly achieved several milestones in Symrise’s validation protocol.
“This partnership represents a major commercial opportunity and confirms the strength of our technology,” said Patrick Charest, CEO of Aplantex.
Together, Aplantex and Symrise are combining innovation and sustainability to pave the way for a new generation of plant-derived ingredients.
Is your supply chain for plant-based molecules underperforming – and affecting your productivity and profitability? Do you want to receive molecules that meet your specifications on a regular and reliable basis? Do your concerns include sustainable development and the circular economy?
We’re here for you!
© Aplantex 2025 | Création faste.ca
Forms protected by reCAPTCHA | Terms of use - Privacy policy
